Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Willow Biosciences Inc. (WLLW.TO)XPhyto TherapeuticsQilian International Holding GroupMediPharm LabsCAVU Resources
Price Information
Current PriceC$1.31$1.90$4.42C$0.47$0.05
52 Week RangeN/AN/AN/ABuyN/A
Overall Score1.
Analysis Score2.
Community Score3.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score0.
Analyst Ratings
Consensus RecommendationN/AN/AN/ABuyN/A
Consensus Price TargetC$2.25N/AN/AC$1.53N/A
% Upside from Price Target71.76% upsideN/AN/A225.53% upsideN/A
Trade Information
Market CapC$161.48 million$127.20 million$158.02 millionC$121.24 million$70.85 million
Average Volume475,81376,621561,8072,632,6563,095,599
Sales & Book Value
Annual RevenueC$10,000.00N/AN/AC$36.01 millionN/A
Price / Sales16,148.11N/AN/A3.37N/A
CashflowC$0.13 per shareN/AN/AC$0.08 per shareN/A
Price / Cash10.00N/AN/A5.59N/A
Book ValueC($0.01) per shareN/AN/AC$0.50 per shareN/A
Price / Book-218.33N/AN/A0.93N/A
Net IncomeN/AN/AN/AN/AN/A
Trailing P/E RatioN/A0.000.00N/A0.00
Forward P/E Ratio
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio16.05%N/AN/A23.54%N/A
Current Ratio10.88%N/AN/A3.36%N/A
Quick Ratio10.70%N/AN/A2.31%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Shares Outstanding123.27 million64.24 million35.75 million257.95 million1.44 billion
Next Earnings DateN/AN/A5/13/2021 (Estimated)6/14/2021 (Estimated)N/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
3/25/2021Willow Biosciences Inc. (WLLW.TO)ATB CapitalLower Price Target
3/26/2020Willow Biosciences Inc. (WLLW.TO)AltaCorp CapitalLower Price Target
4/1/2021MediPharm LabsCanaccord GenuityLower Price Target
4/1/2021MediPharm LabsAlliance Global PartnersLower Price Target
8/17/2020MediPharm LabsPi FinancialLower Price Target
(Data available from 4/20/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.